Page 580 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 580

CHaPTEr 39  HIV and Acquired Immunodeficiency Syndrome                   557


                                                                  include male circumcision and expanded use of ART in infected
           Immune Reconstitution Inflammatory Syndrome            individuals to prevent ongoing infection (treatment as prevention)
           Immune reconstitution inflammatory syndrome (IRIS) is a   or prophylactically in uninfected individuals either before or after
           well-known, if incompletely understood, response in patients   potential exposure to HIV to prevent acquisition of infection
                                     29
           with AIDS  after  initiating ART.  IRIS is characterized by an   (preexposure prophylaxis [PrEP] and postexposure prophylaxis).
           acute paradoxical worsening of inflammatory symptoms of treated
           opportunistic infections or the unmasking of previously subclini-  Male Medical Circumcision
           cal, untreated infections related to the recovery of immune   The penile foreskin contains HIV-susceptible cells and is a
           responses to opportunistic pathogens. IRIS occurs within weeks   potential portal of viral entry. Randomized controlled trials in
           of ART initiation as the memory and effector antigen-activated   several African countries have indicated that male medical cir-
           CD4 T-cell population recovers. A recent systematic review found   cumcision reduces the risk of heterosexually acquiring HIV
                                                                                  37
                                                            28
           that IRIS developed in 13% of patients after initiation of ART.    infection by 50–60%.  The WHO recommends male circumcision
           The most predictive risk factor for the development of IRIS was   as part of a comprehensive HIV prevention package; however,
           a low CD4 T-cell count at the start of ART, with the incidence   condom use and other prevention modalities remain important
           of IRIS increasing exponentially as the CD4 T-cell count declined.   in HIV prevention. There was only a modest benefit for the
           IRIS develops more commonly in patients with cytomegalovirus   female partners of the circumcised men. In fact, in some cir-
           (CMV) retinitis, cryptococcal meningitis, progressive multifocal   cumstances, the risk of transmission to women from men with
           leukoencephalopathy, and tuberculosis. Studies reported that as   HIV infection who have undergone circumcision may be
           many as 4% of patients with IRIS died, but the proportion was   increased, perhaps through exposure to infected blood attributed
           much higher if the syndrome was associated with cryptococcal   to resumption of sexual activity before the circumcision site has
           meningitis. 29                                         fully healed. 37
           Hyperallergenic State Associated With                  Preexposure Prophylaxis
           Immunoreconstitution                                   Recently, two different modalities of ART have been found to
           Another complication possibly associated to IRIS is the appearance   decrease acquisition of HIV when used by uninfected individuals
           of asthma in children who were perinatally infected with HIV   before their exposure to the virus as PrEP: topically applied ARV
                                               30
           and received combination ART since infancy.  This condition   medications and systemic ART. Topically applied ARVs have been
           may be mediated by CD4 T-cell activation, release of Th2-type   shown to block the acquisition of HIV in women from their
           cytokines, and loss of Tregs and tolerance. In support of this   partners with HIV infection by 35–54%. The Centre for the
                            31
           concept, Gingo et al.  reported at least a 20% prevalence of   AIDS Program of Research in South Africa (CAPRISA 004) trial
           asthma in adults with HIV infection compared with that of   was the first double-blind randomized controlled trial demonstrat-
           8.8% in the general population. In a subsequent pediatric study   ing the efficacy of vaginally inserted gel containing the ARV
           in which pulmonary function testing was objectively measured   medication tenofovir disoproxil fumarate, compared with a
           by spirometry, the following findings emerged: Nonreversible   placebo gel, in preventing HIV transmission from men with
           obstructive pulmonary disease was present in youth who had   HIV infection to their uninfected partners. Vaginal PrEP represents
           been perinatally infected with HIV and possibly in those exposed   a promising intervention for preventing heterosexual transmission
           to HIV but were uninfected. This pulmonary disorder contains   of HIV to women. This method may be particularly effective
           elements of asthma and chronic obstructive pulmonary disease   because women are able to initiate and control its use to protect
           (COPD) and closely resembles the asthma–COPD overlap syn-  themselves from infection.
           drome. Chronic infections and immune dysregulation appears
           to play a significant role in this complication of HIV infection. 32  Prophylactic Antiretroviral Therapy
                                                                  ARVs taken prophylactically have also been shown to be effective
           PREVENTION                                             in reducing the transmission of HIV both in MSM and in
                                                                  heterosexual individuals and couples. The multinational Preex-
           Prevention of Mother-to-Child Transmission             posure Prophylaxis Initiative trial demonstrated that daily oral
           More than 90% of children living with HIV worldwide were   combination therapy with emtricitabine and tenofovir disoproxil
           infected through mother-to-child transmission during pregnancy,   fumarate (FTC-TDF) reduced the incidence of HIV among MSM
                                                    33
           around the time of birth, or through breastfeeding.  Efforts to   by 44% compared with placebo. Daily oral FTC-TDF was also
           prevent this transmission hold the most promise in reducing the   shown to reduce HIV incidence among heterosexual individuals
           number of children infected with HIV, and these efforts include (i)   by 63–78% and by 73% among heterosexual discordant couples.
           early identification of HIV infection in pregnant women through   Despite these successful trials, preliminary results of one PrEP
           routine antenatal testing; (ii) provision of ARV medications to   trial  have failed to  show similar  efficacy for preventing HIV
           both the pregnant woman and her infant 34,35 ; (iii) delivery by elec-  acquisition among heterosexual women.
           tive cesarean section, when indicated; (iv) complete avoidance of
           breastfeeding when safe and sustainable alternatives are available;   Expanded Treatment With Antiretroviral Therapy
           (v) widespread availability of educational programs addressing   The expanded use of ART in infected individuals has been shown
           HIV infection; (vi) prevention of HIV perinatal transmission;   to reduce HIV transmission to uninfected partners. Both “Treat-
           and (vii) HIV counseling and testing services. 35,36   ment as Prevention” and “Test and Treat” strategies involve the
                                                                  use of ART in individuals who do not otherwise meet the criteria
           Prevention of Sexual Transmission                      for ART initiation with the express purpose of reducing transmis-
           Several biomedical interventions have the potential for radically   sion to others. In both approaches, ART is initiated regardless
           changing  the  patterns and  rates  of  HIV  transmission. These   of CD4 count or viral load to reduce the viral load in the genital
   575   576   577   578   579   580   581   582   583   584   585